Cancer Epidemiology in Elderly Patients

tibbi onkoloji ozel 13-4 kapak

Hakan TABANa, Saadettin KILIÇKAPb

aHacettepe Üniversitesi Tıp Fakültesi, Tıbbi Onkoloji BD, Ankara, TÜRKİYE
bHacettepe Üniversitesi Kanser Enstitüsü, Prevantif Onkoloji BD, Ankara, TÜRKİYE

ABSTRACT
Sixty percent of newly diagnosed cancers and %70 of cancer-related deaths occur in a population aged 65 years and over. The increase in the world population and proportion of elderly people will lead to a global increase in cancer incidence. With the contribution of recent developments in the treatment of cancer, the prevalence of cancer survivors and cancer prevalence will increase. In developed and developing countries, the incidence rate in elderly men is highest in prostate, lung and colorectal cancer, respectively (except non- melanoma skin cancers). In older women, the highest incidence rate is breast, colorectal cancer and lung cancer, respectively. In underdeveloped countries, the incidence rate of cervix, hepatocellular cancer and oral cavity cancers, which are highly associated with infection and socioeconomic conditions, is still high. According to GLOBOCAN 2018, the most common causes of cancer related death in elderly men are lung, colorectal cancer and stomach cancer; lung, breast and colorectal cancer in older women, respectively. The incidence of cancer in the elderly and consequently the mortality rate are predicted to increase further in the coming years.
Keywords: Cancer; elderly; epidemiology

Referanslar

  1. Cope DG. Cancer and the Aging. In: Diane G. Cope AmR, ed. An Evidence-Based Approach to the Treatment and Care of the Older Adult with Cancer. 1st ed: Oncology Nursing Society; 2006.
  2. Schrijvers D. Esmo Handbook of Cancer in the Senior Patient. 2nd ed. Switzerland: ESmO; 2015.
  3. Fidler mm, Bray F, Soerjomataram I. The global cancer burden and human development: A review. Scandinavian journal of public health. 2018;46(1):27-36. [Crossref]  [PubMed]
  4. Buntinx F, Campbell C, van den Akker m. Cancer in the elderly. Journal of cancer epidemiology. 2014;2014:872029-872029. [Crossref]  [PubMed]  [PMC]
  5. Harding C, Pompei F, Wilson R. Peak and decline in cancer incidence, mortality, and prevalence at old ages. Cancer. 2012;118(5):1371-86. [Crossref]  [PubMed]
  6. Average Number of New Cases per Year and Age-Specific Incidence Rates per 100,000 Population, uK, 2013-2015. Cancer Research uK; 2019. Accessed 01.04.2019. [Link]
  7. Franceschi S, La vecchia C. Cancer epidemiology in the elderly. Critical reviews in oncology/hematology. 2001;39(3):219-26. [Crossref]  [PubMed]
  8. İ. şencan BK. Türkiye Kanser İstatistikleri. Ankara: T.C. Sağlık Bakanlığı Türkiye Halk Sağlığı Kurumu;2017.
  9. Marosi C, Köller m. Challenge of cancer in the elderly. ESmO Open. 2016;1(3):e000020. [Crossref]  [PubMed]  [PMC]
  10. Navarrete-Reyes AP, Soto-Perez-de-Celis E, Hurria A. Cancer and Aging: A Complex Biological Association. Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion. 2016;68(1):17-24.
  11. Siegel RL, miller KD, Jemal A. Cancer statistics, 2019. CA: A Cancer Journal for Clinicians. 2019;69(1):7-34. [Crossref]  [PubMed]
  12. Hansen J. Common cancers in the elderly. Drugs & aging. 1998;13(6):467-78. [Crossref]  [PubMed]
  13. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians. 2018;68(6):394- 424. [Crossref]  [PubMed]
  14. Estimated age-standardized incidence rates (World) in 2018, all cancers, both sexes, ages 65+. International Agency for Research on Cancer; 2018. Accessed 30.03.2019. [Link]
  15. İ. şencan GNİ. Türkiye Kanser İstatistikleri. Ankara: T.C. Sağlık Bakanlığı Türkiye Halk Sağlığı Kurumu;2016.
  16. Estimated age-standardized mortality rates (World) in 2018, all cancers, both sexes, ages 65+. IACR; 2018. Accessed 30.03.2019. [Link]